Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis
These findings underscore the importance of considering cognitive health when making pharmacologic decisions for this population.
Authors
- Cory Wernimont (ORCID: https://orcid.org/0000-0002-3513-8152)
- Keara Ginell (ORCID: https://orcid.org/0000-0001-6928-1080)
- Tiffany J. Braley (ORCID: https://orcid.org/0000-0003-0680-7828)
- Nora E. Fritz (ORCID: https://orcid.org/0000-0002-4548-1077)
- Anna L. Kratz (ORCID: https://orcid.org/0000-0002-3664-3898)
- Dawn M. Ehde (ORCID: https://orcid.org/0000-0002-9555-2347)
- Kevin N. Alschuler (ORCID: https://orcid.org/0000-0003-2621-3461)
- Jeeyeon Kim (ORCID: https://orcid.org/0000-0001-7913-4463)
- Serena Marecle
Institutions
- Wayne State University (US)
- University of Washington (US)
- University of Michigan (US)
- Michigan Medicine (US)
- Institute of Neuroimmunology of the Slovak Academy of Sciences (SK)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1016/j.msard.2025.106854
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00